Alpha Teknova, Inc. (TKNO)
TKNO Stock Price Chart
Explore Alpha Teknova, Inc. interactive price chart. Choose custom timeframes to analyze TKNO price movements and trends.
TKNO Company Profile
Discover essential business fundamentals and corporate details for Alpha Teknova, Inc. (TKNO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
25 Jun 2021
Employees
173.00
Website
https://www.teknova.comCEO
Stephen Gunstream
Description
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.
TKNO Financial Timeline
Browse a chronological timeline of Alpha Teknova, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Aug 2026
EPS estimate is -$0.08, while revenue estimate is $10.96m.
Earnings released on 6 May 2026
EPS came in at -$0.08 surpassing the estimated -$0.09 by +13.57%, while revenue for the quarter reached $11.08m , beating expectations by +8.32%.
Earnings released on 26 Feb 2026
EPS came in at -$0.09 matching the estimated -$0.09, while revenue for the quarter reached $9.98m , beating expectations by +3.03%.
Earnings released on 6 Nov 2025
EPS came in at -$0.08 surpassing the estimated -$0.09 by +14.75%, while revenue for the quarter reached $10.45m , beating expectations by +8.68%.
Earnings released on 7 Aug 2025
EPS came in at -$0.07 surpassing the estimated -$0.10 by +30.25%, while revenue for the quarter reached $10.29m , beating expectations by +3.95%.
Earnings released on 8 May 2025
EPS came in at -$0.09 surpassing the estimated -$0.11 by +18.18%, while revenue for the quarter reached $9.80m , missing expectations by -1.34%.
Earnings released on 4 Mar 2025
EPS came in at -$0.11 surpassing the estimated -$0.12 by +8.33%, while revenue for the quarter reached $9.27m , beating expectations by +5.63%.
Earnings released on 7 Nov 2024
EPS came in at -$0.15 falling short of the estimated -$0.11 by -36.36%, while revenue for the quarter reached $9.58m , beating expectations by +4.16%.
Earnings released on 13 Aug 2024
EPS came in at -$0.13 surpassing the estimated -$0.16 by +18.75%, while revenue for the quarter reached $9.61m , beating expectations by +1.63%.
Earnings released on 13 May 2024
EPS came in at -$0.20 surpassing the estimated -$0.24 by +16.67%, while revenue for the quarter reached $9.29m , beating expectations by +9.89%.
Earnings released on 11 Mar 2024
EPS came in at -$0.22 surpassing the estimated -$0.23 by +4.35%, while revenue for the quarter reached $7.87m , missing expectations by -5.58%.
Earnings released on 9 Nov 2023
EPS came in at -$0.34 falling short of the estimated -$0.28 by -21.43%, while revenue for the quarter reached $8.17m , missing expectations by -0.83%.
Earnings released on 10 Aug 2023
EPS came in at -$0.25 surpassing the estimated -$0.26 by +3.85%, while revenue for the quarter reached $11.53m , beating expectations by +18.76%.
Earnings released on 10 May 2023
EPS came in at -$0.31 falling short of the estimated -$0.30 by -3.33%, while revenue for the quarter reached $9.12m , beating expectations by +12.45%.
Earnings released on 15 Mar 2023
EPS came in at -$0.47 falling short of the estimated $0.34 by -238.24%, while revenue for the quarter reached $7.89m , beating expectations by +2.45%.
Earnings released on 9 Nov 2022
EPS came in at -$0.21 surpassing the estimated -$0.29 by +27.59%, while revenue for the quarter reached $10.69m , beating expectations by +21.22%.
Earnings released on 10 Aug 2022
EPS came in at -$0.22 surpassing the estimated -$0.25 by +12.00%, while revenue for the quarter reached $11.69m , beating expectations by +7.70%.
Earnings released on 11 May 2022
EPS came in at -$0.20 matching the estimated -$0.20, while revenue for the quarter reached $11.15m , beating expectations by +10.73%.
Earnings released on 15 Mar 2022
EPS came in at -$0.13 surpassing the estimated -$0.17 by +23.53%, while revenue for the quarter reached $10.11m , beating expectations by +19.87%.
Earnings released on 10 Nov 2021
EPS came in at -$0.12 matching the estimated -$0.12, while revenue for the quarter reached $9.39m , meeting expectations.
Earnings released on 11 Aug 2021
EPS came in at -$0.52 falling short of the estimated -$0.09 by -477.78%, while revenue for the quarter reached $8.31m , meeting expectations.
TKNO Stock Performance
Access detailed TKNO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
